Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 22,998Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Pfizer Inc

02 12Pierre Fabre

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2018-06-27

Application Number : 210496

Regulatory Info : DISCN

Registration Country : USA

blank

02

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE;ORAL

Dosage Strength : 75MG

Packaging :

Approval Date : 2018-06-27

Application Number : 210496

Regulatory Info : RX

Registration Country : USA

blank

03

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE

Dosage Strength : 75MG

Packaging :

Approval Date :

Application Number : 2513099

Regulatory Info : Prescription

Registration Country : Canada

blank

04

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 50mg

Packaging :

Approval Date : 20/09/2018

Application Number : 20170731000076

Regulatory Info : Approved

Registration Country : Sweden

blank

05

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 75mg

Packaging :

Approval Date : 20/09/2018

Application Number : 20170731000083

Regulatory Info : Approved

Registration Country : Sweden

blank

06

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 50mg

Packaging :

Approval Date : 01/11/2019

Application Number : 66795

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 75mg

Packaging :

Approval Date : 01/11/2019

Application Number : 66795

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 50MG

Packaging :

Approval Date : 2018-10-04

Application Number : 1181314001

Regulatory Info : Authorized

Registration Country : Spain

blank

09

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 75MG

Packaging :

Approval Date : 2018-10-04

Application Number : 1181314002

Regulatory Info : Authorized

Registration Country : Spain

blank

10

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

AIChE Annual Meeting
Not Confirmed
arrow
arrow
AIChE Annual Meeting
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank